Clinical Manufacturing
Scalable, Reliable Production
Experience the evolution of therapeutic cell production at Roswell Park Comprehensive Cancer Center, which commenced with a single processing room cGMP facility in 2012. Fast forward to the present, our expansive 2,574 sq. ft. cGMP facility, equipped with four ISO7 processing rooms, was established in 2014. Anticipating and responding to market demands, we are rapidly expanding our capacity. By the end of 2024, we will introduce 14 additional state-of-the-art clean room suites to accommodate your CDMO projects.
The cell manufacturing solutions at the Roswell Park GMP Engineering & Cell Manufacturing (GEM) Facility are not only flexible but also customizable.
We seamlessly scale production from initial bench research to First in Human clinical trials, providing support for existing clinical trials in manufacturing, testing, and product release. This translates to accelerated pipelines, heightened resource efficiencies, and enhanced cost-effectiveness.
Choosing Roswell Park as your partner ensures risk mitigation. Your project will be overseen by industry veterans, experienced scientists, and qualified technicians, each equipped with unparalleled skills and expertise. If you're poised to expand your reach, engage with a GMP expert at Roswell Park today and experience the pinnacle of excellence in therapeutic cell production.
Growing to Meet Demand
Introducing the upcoming Roswell Park GMP Engineering & Cell Manufacturing Facility, poised to be the inaugural among two premier cell and gene therapy hubs in the state of New York. As a pivotal initiative, we take the lead in forming a consortium comprising cancer centers across New York state, aiming to expedite the recruitment of patients for upcoming clinical trials. Join us in this groundbreaking venture, positioning your organization at the forefront of cutting-edge cell and gene therapy advancements in New York.
“The resources you have access to through Roswell Park's GMP Engineering and Cell Manufacturing Facility are unmatched. Your project requires a dynamic, multidisciplinary team where all the various aspects come together to move an idea from the clinical research phase to standard of care. That’s what we offer at Roswell Park.”
Peter Maslak, MDDirector, Flow & Immune Analysis Shared Resource